 Ascendis Pharma AS ASND Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Tim Lee - Senior Director, Investor Relations Jan Mikkelsen - President Chief Executive Officer Scott Smith - Senior Vice President Chief Financial Officer Stina Singel - Head of Clinical Development Oncology Birgitte Volck - Senior Vice President Head of Clinical Development Medical Affairs Endocrinology Rare Diseases Joe Kelly - Head of US Commercial Endocrinology Conference Call Participants Jess Fye - JPMorgan Josh Schimmer - Evercore ISI David Lebowitz - Citibank Li Watsek - Cantor Paul Choi - Goldman Sachs Vikram Purohit - Morgan Stanley Leland Gershell - Oppenheimer Joseph Schwartz - SVB Securities Andreas Argyrides - Wedbush Securities Yaron Werber - Cowen Operator Good day, and thank you for standing by. Welcome to the Ascendis Pharma Third Quarter Earnings Conference Call. 